Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
$482K Sell
1,850
-1
-0.1% -$297 0.03% 140
2024
Q3
$596K Buy
1,851
+13
+0.7% +$4.25K 0.04% 115
2024
Q2
$574K Sell
1,838
-802
-30% -$236K 0.04% 123
2024
Q1
$751K Buy
2,640
+45
+2% +$13.2K 0.06% 95
2023
Q4
$747K Sell
2,595
-14
-0.5% -$3.81K 0.07% 86
2023
Q3
$701K Buy
2,609
+219
+9% +$54.7K 0.08% 73
2023
Q2
$531K Buy
2,390
+750
+46% +$174K 0.07% 107
2023
Q1
$396K Sell
1,640
-335
-17% -$82.2K 0.06% 94
2022
Q4
$519K Buy
1,975
+180
+10% +$48.3K 0.09% 52
2022
Q3
$405K Buy
1,795
+272
+18% +$65.9K 0.09% 60
2022
Q2
$371K Sell
1,523
-42
-3% -$10.3K 0.08% 69
2022
Q1
$378K Buy
1,565
+364
+30% +$83.6K 0.07% 81
2021
Q4
$270K Sell
1,201
-75
-6% -$15.8K 0.05% 126
2021
Q3
$271K Sell
1,276
-397
-24% -$91.4K 0.06% 115
2021
Q2
$408K Sell
1,673
-3
-0.2% -$738 0.09% 63
2021
Q1
$417K Buy
1,676
+395
+31% +$94.3K 0.1% 57
2020
Q4
$344K Hold
1,281
0.09% 67
2020
Q3
$326K Buy
1,281
+16
+1% +$3.96K 0.09% 52
2020
Q2
$298K Buy
+1,265
New +$289K 0.09% 56
2019
Q4
Sell
-1,298
Closed -$251K 63
2019
Q3
$251K Buy
+1,298
New +$249K 0.09% 50
2016
Q4
Sell
-1,900
Closed -$317K 23
2016
Q3
$317K Hold
1,900
0.18% 20
2016
Q2
$289K Hold
1,900
0.17% 19
2016
Q1
$285K Sell
1,900
-754
-28% -$112K 0.17% 20
2015
Q4
$431K Buy
2,654
+754
+40% +$119K 0.26% 18
2015
Q3
$263K Hold
1,900
0.17% 22
2015
Q2
$292K Hold
1,900
0.17% 24
2015
Q1
$304K Hold
1,900
0.18% 26
2014
Q4
$303K Buy
+1,900
New +$296K 0.18% 26

Other funds holding AMGN

Geller Advisors's AMGN Position: Q4 2024 in Review

Geller Advisors reduced its Amgen (AMGN) stake by 0.05% in Q4 2024, selling an estimated $297 and leaving 1,850 shares worth $482K. The position accounts for 0.03% of the portfolio, ranked #140.

Geller Advisors first reported a position in AMGN in Q4 2014 and has held it in 28 quarters since. The position peaked at $751K in Q1 2024. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • Geller Advisors held 1,850 shares of Amgen worth $482K as of Q4 2024.
  • Geller Advisors sold 1 Amgen share in Q4 2024, an estimated $297.
  • Amgen made up 0.03% of Geller Advisors's portfolio in Q4 2024, its #140 holding.
  • Geller Advisors first reported a position in Amgen in Q4 2014 and has held it in 28 quarters since.
  • Geller Advisors's Amgen position peaked at $751K in Q1 2024.
  • 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on Geller Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.